Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK

被引：0
|
作者：
Phil McEwan
Simon Dixon
Keshwar Baboolal
Pete Conway
Craig J. Currie
机构：
[1] Cardiff University,School of Mathematics
[2] University of Sheffield,School of Health and Related Research
[3] University Hospital of Wales,Department of Renal Medicine
[4] Wyeth Laboratories-UK,Health Economics
[5] University of Wales College of Medicine,Department of Medicine
[6] Cardiff Research Consortium,undefined
来源：
PharmacoEconomics | 2006年 / 24卷
关键词：
Tacrolimus; Peritoneal Dialysis; Acute Rejection; Sirolimus; Graft Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Introduction: Immunosuppressive therapy is required to prevent graft rejection. Calcineurin inhibitors such as tacrolimus are paradoxically toxic to the kidney, whereas sirolimus (rapamycin; Rapamune®) is not generally associated with the nephrotoxicity of CNIs. The purpose of this study was to evaluate the relative cost utility of sirolimus versus tacrolimus for the primary prevention of graft rejection in renal transplant recipients in the UK.
引用
收藏
页码：67 / 79
页数：12
相关论文
共 50 条
  • [1] Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
    McEwan, P
    Dixon, S
    Baboolal, K
    Conway, P
    Currie, CJ
    [J]. PHARMACOECONOMICS, 2006, 24 (01) : 67 - 79
  • [2] Evaluation of the cost utility of sirolimus versus tacrolimus for immunosuppression for renal transplantation in the United Kingdom
    Currie, CJ
    Dixon, S
    Conway, P
    McEwan, P
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 800 - 800
  • [3] Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
    McEwan, P
    Baboolal, K
    Conway, P
    Currie, CJ
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (11) : 1834 - 1846
  • [4] Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
    Guerra Junior, Augusto Afonso
    Silva, Grazielle Dias
    Gurgel Andrade, Eli Iola
    Cherchiglia, Mariangela Leal
    Costa, Juliana de Oliveira
    Almeida, Alessandra Maciel
    Acurcio, Francisco de Assis
    [J]. REVISTA DE SAUDE PUBLICA, 2015, 49
  • [5] Improvements in glycaemic control following conversion of tacrolimus to sirolimus following renal transplantation
    Winburn, I
    Reinoehl, S
    Brown, A
    Kardasz, S
    Talbot, D
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (02): : A26 - A26
  • [6] COMPLIANCE TO TACROLIMUS AND SIROLIMUS IN RENAL TRANSPLANTATION
    Sequeira, C.
    Mota, A.
    Ribeiro, Fontes C. A.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 145 - 145
  • [7] Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation
    Formica, RN
    Lorber, KM
    Friedman, AL
    Bia, MJ
    Lakkis, F
    Smith, JD
    Lorber, MI
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 95S - 98S
  • [8] A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation
    Craig, AM
    McKechnie, T
    McKenna, M
    Klein, W
    Schindler, TM
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1646 - 1648
  • [9] NONCOMPLIANCE TO TACROLIMUS AND SIROLIMUS IN RENAL TRANSPLANTATION
    Sequeira, Clara
    Isabel, Odete
    Mota, Alfredo
    Ribeiro, Carlos Fontes
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 112 - 112
  • [10] Tacrolimus versus cyclosporin in renal transplantation in Italy: Cost-minimisation and cost-effectiveness analyses
    Lazzaro, C
    McKechnie, T
    McKenna, M
    [J]. JOURNAL OF NEPHROLOGY, 2002, 15 (05) : 580 - 588
12345